• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2-氨基-4,5,6,7,8,9-六氢环辛[b]噻吩作为 A1 腺苷受体别构调节剂的合成与生物评价。

The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor.

机构信息

Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

出版信息

Bioorg Med Chem Lett. 2011 Jun 15;21(12):3704-7. doi: 10.1016/j.bmcl.2011.04.080. Epub 2011 May 4.

DOI:10.1016/j.bmcl.2011.04.080
PMID:21612922
Abstract

A series of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes were prepared and evaluated as potential allosteric modulators of the A(1) adenosine receptor (AR). The structure-activity relationships of the 3-position were explored along with varying the size of the cycloalkyl ring. 2-Aminothiophenes with amide and hydrazide groups in the 3-position were completely inactive in an A(1)-AR-mediated ERK1/2 phosphorylation assay, yet most of the 3-benzoyl substituted compounds exhibited allosteric effects on responses mediated by the orthosteric agonist, R-PIA. Despite finding an increase in both agonistic and allosteric activities by going from a cyclopentyl ring to a cyclohexyl ring in the 3-benzoyl series, decreases were observed when further increasing the ring size. Varying the substituents on the phenyl ring of the 3-benzoyl group also affected the activity of these compounds.

摘要

一系列 2-氨基-4,5,6,7,8,9-六氢环辛[b]噻吩被制备并评估为 A(1)腺苷受体 (AR) 的潜在别构调节剂。还探索了 3-位的结构-活性关系,同时改变环烷基环的大小。3-位具有酰胺和酰肼基团的 2-氨基噻吩在 A(1)-AR 介导的 ERK1/2 磷酸化测定中完全没有活性,但大多数 3-苯甲酰取代的化合物对正位激动剂 R-PIA 介导的反应表现出别构效应。尽管在 3-苯甲酰系列中,从环戊基环变为环己基环会增加激动剂和别构活性,但当进一步增加环的大小时,活性会降低。3-苯甲酰基苯环上取代基的变化也会影响这些化合物的活性。

相似文献

1
The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor.2-氨基-4,5,6,7,8,9-六氢环辛[b]噻吩作为 A1 腺苷受体别构调节剂的合成与生物评价。
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3704-7. doi: 10.1016/j.bmcl.2011.04.080. Epub 2011 May 4.
2
Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes.腺苷A1受体的变构调节剂:4-取代-2-氨基-3-苯甲酰基噻吩的合成与药理学评价
J Med Chem. 2009 Jul 23;52(14):4543-7. doi: 10.1021/jm9002582.
3
Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor.新型 2-氨基-3-苯甲酰基噻吩衍生物的合成与表征作为腺苷 A(1)受体的别构激动剂和调节剂。
J Med Chem. 2012 Mar 8;55(5):2367-75. doi: 10.1021/jm201600e. Epub 2012 Feb 17.
4
Effects of conformational restriction of 2-amino-3-benzoylthiophenes on A(1) adenosine receptor modulation.2-氨基-3-苯甲酰噻吩构象限制对 A(1) 腺苷受体调节的影响。
J Med Chem. 2010 Sep 23;53(18):6550-9. doi: 10.1021/jm1008538.
5
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.2-氨基-3-(4-氯苯甲酰基)-4-[N-(取代)哌嗪-1-基]噻吩作为A1腺苷受体有效变构增强剂的合成及生物学评价
J Med Chem. 2008 Sep 25;51(18):5875-9. doi: 10.1021/jm800586p. Epub 2008 Aug 26.
6
5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers.5-取代的2-氨基噻吩作为A1腺苷受体变构增强剂
Bioorg Med Chem. 2008 Feb 1;16(3):1319-27. doi: 10.1016/j.bmc.2007.10.065. Epub 2007 Oct 23.
7
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.新型2-氨基-3-芳酰基-4-新戊基-5-取代噻吩衍生物作为A₁腺苷受体变构增强剂的合成及生物学评价
Bioorg Med Chem. 2014 Jan 1;22(1):148-66. doi: 10.1016/j.bmc.2013.11.043. Epub 2013 Dec 1.
8
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.新型2-氨基-3-萘甲酰基噻吩作为A1腺苷受体变构增强剂的合成及生物学效应
J Med Chem. 2003 Feb 27;46(5):794-809. doi: 10.1021/jm0210212.
9
Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor.2-氨基-3-杂芳酰基噻吩的合成及其作为人A1受体潜在变构增强剂的活性评估。
Eur J Med Chem. 2004 Oct;39(10):855-65. doi: 10.1016/j.ejmech.2004.06.009.
10
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.2-氨基-3-芳酰基-4-[(4-芳基哌嗪-1-基)甲基]噻吩的构效关系。第 2 部分:研究芳基哌嗪部分的苯基上不同取代基对 A₁ 腺苷受体变构增强活性的影响。
Bioorg Med Chem. 2012 Jan 15;20(2):996-1007. doi: 10.1016/j.bmc.2011.11.044. Epub 2011 Dec 1.

引用本文的文献

1
Structure-based discovery of positive allosteric modulators of the A adenosine receptor.基于结构的A1腺苷受体正变构调节剂的发现
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2421687122. doi: 10.1073/pnas.2421687122. Epub 2025 Jul 7.
2
Small molecule allosteric modulation of the adenosine A receptor.小分子变构调节腺苷 A 受体。
Front Endocrinol (Lausanne). 2023 Jun 26;14:1184360. doi: 10.3389/fendo.2023.1184360. eCollection 2023.
3
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.
通过变构和偏向性微调毒蕈碱型乙酰胆碱受体信号传导
Front Pharmacol. 2021 Jan 29;11:606656. doi: 10.3389/fphar.2020.606656. eCollection 2020.
4
Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor.回顾性集合对接法研究别构调节剂在腺苷 G 蛋白偶联受体中的作用。
Biochim Biophys Acta Gen Subj. 2020 Aug;1864(8):129615. doi: 10.1016/j.bbagen.2020.129615. Epub 2020 Apr 13.
5
Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A Receptor.别构药物配体在腺苷 A 受体中结合的结构基础。
Sci Rep. 2018 Nov 15;8(1):16836. doi: 10.1038/s41598-018-35266-x.
6
G Protein-coupled Receptor Biased Agonism.G蛋白偶联受体偏向性激动作用
J Cardiovasc Pharmacol. 2016 Mar;67(3):193-202. doi: 10.1097/FJC.0000000000000356.
7
Separation of on-target efficacy from adverse effects through rational design of a bitopic adenosine receptor agonist.通过合理设计双位腺嘌呤受体激动剂,将靶效应与不良反应分离。
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4614-9. doi: 10.1073/pnas.1320962111. Epub 2014 Mar 11.